; and (B) the Committee on Armed Services, the Committee on Foreign Affairs, the Committee on Oversight and Accountability, the Committee on Energy and Commerce, and the Select Committee on Strategic Competition between the United States and the Chinese Communist Party of the House of Representatives. (2) Biotechnology company of concern The term biotechnology company of concern means— (A) the BGI Group, MGI Group, or Complete Genomics, or any subsidiary, parent, affiliate, or successor of such entities; and (B) any entity that— (i) is subject to the jurisdiction, direction, or control of a foreign adversary; (ii) operates primarily in the biotechnology industry; and (iii) the Secretary of Defense deems to pose a risk to the national security of the United States. (3) Biotechnology equipment or service The term biotechnology equipment or service means— (A) any instrument, apparatus, machine, or device, including components and accessories thereof, that is designed for use in the research, development, production, or analysis of biological materials as well as any software, firmware, or other digital components that are specifically designed for use in, and necessary for the operation of, such an instrument, apparatus, machine, or device; (B) any service for the research, development, production, analysis, detection, or provision of information related to biological materials, including— (i) advising, consulting, or support services provided by a biotechnology company of concern with respect to the use or implementation of a instrument, apparatus, machine, or device described in subparagraph (A); and (ii) disease detection, genealogical information, and related services